UCL and Takeda announce a new research partnership
Aims the identification of novel therapeutic targets for neurodegenerative diseases
15-Oct-2015 -
UCL (University College London) and Takeda Pharmaceutical Company Limited announced a new research collaboration to identify and validate novel target genes for the treatment of neurodegenerative disease.
This collaboration will focus on mechanistic approaches for the identification of genes or ...
collaborations
drug development
neurodegenerative diseases
+2